Last reviewed · How we verify
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
The purpose of this study is to evaluate whether a semi-quantitative interpretation using the liver SUVmax as reference can better interpret 18F-FDG PET/CT and predict disease progression during chemotherapy or survival in PTCL.
Details
| Lead sponsor | Peking University Cancer Hospital & Institute |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 80 |
| Start date | Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Lymphoma, T-Cell, Peripheral
Interventions
- 18F-FDG PET/CT
Countries
China